Self-Regulation of Genomic Studies and Prospects of Personified Medicine

A secular trend of the development of medicine in the 20th century was on the ways of strengthening the foundations of public health, formation of systems of affordable medical care. Human genome deciphering opens wide prospects for using the obtained data in medicine. In recent years commercial medical organizations have been developing genetic research and personal genomic testing services. The paper is devoted to the analysis of the importance of legal self-regulation in the field of genomic counseling in the Russian Federation. The authors investigate the prospects of the introduction of personalized medicine and limitations that arise today in one of the areas of the approach under consideration, namely: forecasting predisposition to diseases of mixed nature, which is related to the peculiarities of development of medical and demographic situation in the world. The question is raised about the need for broad population studies to verify the risk values for diseases with low genetic determinacy. The authors conclude that it is impossible to predict what medicine of the future will be, but the results of genome decryption and increasing availability of personal data represent a unique social phenomenon that should be developed within the legal framework. In the coming years, the debate on the role of legal mechanisms in the self-regulation of genetic research and genetic services will become increasingly important. At the international level, this discussion will be focused on the fundamental issue of respect for individual rights in the interpretation of the data received. As genetic advice evolves, the issue of responsibility for the information provided and the availability of national regulatory mechanisms within the framework of state regulation or self-regulated professional associations will become a key concern.

1. Varlen MV, Mashkova KV, Zenin SS, Bartsits AL, Suvorov G. poisk obshchikh printsipov samoregulirovaniya genomnykh issledovaniy v kontekste obespecheniya prioritetnoy zashchity prav i zakonnykh interesov lichnosti [Search for general principles of self-regulation of genomic studies in the context of ensuring priority protection of rights and legitimate interests of the person]. Problemy prava [Issues of Law]. 2019;3(72):11—18. (In Russ.)

2. Erugina MV, Krom IL, Shmerkevich AB, Dorogoykin DL, Zhuzhlova NY, Shigaev N. N., Bochkareva GN. Dostupnost meditsinskoy pomoshchi kak obligatnyy sotsialnyy prediktor zdorovya naseleniya v Rossii (obzor) [Accessibility of medical care as a bond social predictor of population health in Russia (review)]. Saratov Journal of Medical Scientific Research . 2016;12(2):101—105. (Rus.)

3. Nazarov V, Sisigina N. Ekonomika geneticheskogo zdravookhraneniya [Economics of genetic health care]. Economic Policy. 2018;13(6):188-213. (In Russ.)

4. Sakhipgareeva AR. Gosudarstvennyy kontrol interpretatsii genomnykh issledovaniy i meditsinskikh prilozheniy v Soedinennykh Shtatakh Ameriki [State Control of Interpretation of Genomic Research and Medical Applications in the United States of America]. RUDN Journal of Law. 2018;22(3):329-345. (In Russ.)

5. Shishkin SV, Bondarenko NV, Burdyak AYa. Analiz razlichiy v dostupnosti meditsinskoy pomoshchi dlya naseleniya Rossii [Analysis of differences in the availability of medical care for the population of Russia]. Independent Institute of Social Policy. Vol. 52; 2007. (In Russ.)

6. Galton F. Eugenics: its definition, scope, and aims. The American Journal of Sociology. 1904;X(1).

7. Meloni M, Testa G. Scrutinizing the epigenetics revolution. BioSocieties. 2014;9:431—456. Available from: https://link.springer.com/article/10.1057/biosoc.2014.22 (cited 30 June 2020).

8. Omran AR. The epidemiological transition: A theory of the epidemiology of public change. The Milbank Quarterly. 2005;83(4):731—757.

9. Rose G, Khaw Kay-Tee, Marmot M. Rose’s Strategy of Preventive Medicine. Bibliographic Information. Print publication date: 2008. Print ISBN-13:9780192630971. Published to Oxford Scholarship Online: September 2009.

10. Schwartz S., Diez-Roux R. Commentary: Causes of incidence and causes of cases-a Durkheimian perspective on Rose. International Journal of Epidemiology. 2001;30(3):435—439.

11. Wahdan MH. The epidemiological transition. Eastern Mediterranean Health Journal. 1996;2(1):2.